BIAF — bioAffinity Technologies, Inc.
Price · 2024-08-26 → 2026-08-21
499 daily closes shownAnonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2022-09-01.
Performance
Technicals
Others in Healthcare
Measured signals that fired on BIAF
| date | signal | measured base rate |
|---|---|---|
| 2026-06-22 | Equal lows taken out structure | -0.64% over 21 days · t = -4.75 · n = 55,661 statistically distinguishable from its control group |
| 2026-05-06 | Fair value gap, bearish structure | -0.45% over 21 days · t = -3.29 · n = 108,591 statistically distinguishable from its control group |
| 2026-03-20 | Equal highs taken out structure | -0.70% over 21 days · t = -8.28 · n = 68,636 statistically distinguishable from its control group |
Excess return against a matched control group, on a point-in-time universe that includes delisted companies. Most families do not survive that. How the measurement works →
Insider transactions (Form 4)
| date | insider | what | shares | price | value |
|---|---|---|---|---|---|
| 2025-01-10 | Zannes Maria President & CEO | Grant or award | 37.0K | 0.00 | 0 |
| 2025-01-10 | Zannes Timothy P Secretary, EVP, Gen. Counsel | Grant or award | 8.6K | 0.00 | 0 |
| 2025-01-10 | Reveles Xavier Trinidad Chief Operating Officer | Grant or award | 21.6K | 0.00 | 0 |
| 2025-01-10 | GIRGENTI STEVEN Executive Chairman | Grant or award | 14.8K | 0.00 | 0 |
| 2025-01-10 | Edwards James Michael VP and CFO | Grant or award | 6.2K | 0.00 | 0 |
| 2024-11-05 | Edwards James Michael VP and CFO | Grant or award | 100.0K | 0.00 | 0 |
| 2024-07-01 | Harvey Sandler Revocable Trust | Grant or award | 33.8K | 0.00 | 0 |
| 2024-07-01 | Platt Jamie Director | Grant or award | 33.8K | 0.00 | 0 |
| 2024-07-01 | KNIGHT PETER S Director | Grant or award | 33.8K | 0.00 | 0 |
| 2024-07-01 | Zannes Maria President & CEO | Grant or award | 33.8K | 0.00 | 0 |
Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →
Largest institutional holders
| manager | value | shares |
|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | 212.7K | 55.5K |
| GEODE CAPITAL MANAGEMENT, LLC | 185.0K | 48.3K |
| J. Safra Sarasin Holding AG | 164.0K | 42.6K |
| VANGUARD FIDUCIARY TRUST CO | 119.0K | 31.1K |
| Schonfeld Strategic Advisors LLC | 93.5K | 24.4K |
| STATE STREET CORP | 55.1K | 14.4K |
| NORTHERN TRUST CORP | 48.7K | 12.7K |
| UBS Group AG | 35.3K | 9.2K |
| Tower Research Capital LLC (TRC) | 7.9K | 2.1K |
| Ameritas Advisory Services, LLC | 3.8K | 1.0K |
13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →
Latest SEC filings
| form | filed | period | |
|---|---|---|---|
| 8-K | 2026-08-20 | 2026-08-20 | on EDGAR ↗ |
| 8-K | 2026-08-18 | 2026-08-18 | on EDGAR ↗ |
| 8-K | 2026-08-14 | 2026-08-12 | on EDGAR ↗ |
| 10-Q | 2026-08-07 | 2026-06-30 | on EDGAR ↗ |
| 8-K | 2026-08-07 | 2026-08-07 | on EDGAR ↗ |
| 8-K | 2026-07-31 | 2026-07-30 | on EDGAR ↗ |
| 8-K | 2026-07-27 | 2026-07-27 | on EDGAR ↗ |
| 8-K | 2026-07-22 | 2026-07-22 | on EDGAR ↗ |
Short selling
This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →
Recent headlines
- Bioaffinity Technologies, Inc. (BIAF) filed form 8-K · 2026-08-20 · SEC EDGAR
- Bioaffinity Technologies, Inc. (BIAF) filed form 8-K · 2026-08-18 · SEC EDGAR
- Bioaffinity Technologies, Inc. (BIAF) filed form 8-K · 2026-08-14 · SEC EDGAR
Ask the AI about BIAF
The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.
Everything on this page is live in the terminal.
Charts, filings, insider flow and the AI — open without an account.
Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →